ZERBE ROBERT L MD 4
4 · Vericel Corp · Filed Feb 7, 2025
Insider Transaction Report
Form 4
Vericel CorpVCEL
ZERBE ROBERT L MD
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-05$13.05/sh+2,500$32,625→ 29,095 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-05+2,500→ 7,500 totalExercise: $13.05Exp: 2028-05-02→ Common Stock (2,500 underlying) - Sale
Common Stock
2025-02-05$62.50/sh−2,500$156,250→ 26,595 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024.
- [F2]These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019.